Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000920465-19-000011)

Filing Details

Accession Number:: 0000920465-19-000011
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-01-09 21:29:45
Reporting Period:: 2019-01-07

Accepted Time:: 2019-01-09 21:29:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
920465	La Jolla Pharmaceutical Co	LJPC	Biological Products, (No Disgnostic Substances) (2836)	330361285

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1287235	F George Tidmarsh	C/O La Jolla Pharmaceutical Company, 4550 Towne Centre Court San Diego CA 92121	President, Ceo & Secretary	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-01-07	82	$5.85	1,281,408	No	4	P	Direct
Common Stock	Acquisiton	2019-01-07	287	$5.85	1,281,695	No	4	P	Direct
Common Stock	Acquisiton	2019-01-07	98	$5.85	1,281,793	No	4	P	Direct
Common Stock	Acquisiton	2019-01-07	397	$5.85	1,282,190	No	4	P	Direct
Common Stock	Acquisiton	2019-01-07	700	$5.85	1,282,890	No	4	P	Direct
Common Stock	Acquisiton	2019-01-07	436	$5.85	1,283,326	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	22,000	Indirect	By children